Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trial
Purpose Chemotherapy-induced nausea and vomiting (CINV) remain significant clinical problems, especially in the delayed phase (24-120 h after chemotherapy). Amisulpride is a dopamine D2/D3-receptor...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2019
|
| In: |
Supportive care in cancer
Year: 2018, Jahrgang: 27, Heft: 7, Pages: 2699-2705 |
| ISSN: | 1433-7339 |
| DOI: | 10.1007/s00520-018-4564-8 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1007/s00520-018-4564-8 Verlag, Volltext: https://link.springer.com/article/10.1007/s00520-018-4564-8 
|
| Verfasserangaben: | J. Herrstedt, Y. Summers, K. Jordan, J. von Pawel, A.H. Jakobsen, M. Ewertz, S. Chan, J.D. Naik, M. Karthaus, S. Dubey, R. Davis, G.M. Fox |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1669583937 | ||
| 003 | DE-627 | ||
| 005 | 20240323101237.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 190722r20192018xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00520-018-4564-8 |2 doi | |
| 035 | |a (DE-627)1669583937 | ||
| 035 | |a (DE-599)KXP1669583937 | ||
| 035 | |a (OCoLC)1341234064 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Herrstedt, Jørn |e VerfasserIn |0 (DE-588)1191135977 |0 (DE-627)1669583791 |4 aut | |
| 245 | 1 | 0 | |a Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy |b a randomised, double-blind, placebo-controlled, dose-ranging trial |c J. Herrstedt, Y. Summers, K. Jordan, J. von Pawel, A.H. Jakobsen, M. Ewertz, S. Chan, J.D. Naik, M. Karthaus, S. Dubey, R. Davis, G.M. Fox |
| 264 | 1 | |c 2019 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a First online: 28 November 2018 | ||
| 500 | |a Gesehen am 22.07.2019 | ||
| 520 | |a Purpose Chemotherapy-induced nausea and vomiting (CINV) remain significant clinical problems, especially in the delayed phase (24-120 h after chemotherapy). Amisulpride is a dopamine D2/D3-receptor... | ||
| 534 | |c 2018 | ||
| 700 | 1 | |a Jordan, Karin |d 1974- |e VerfasserIn |0 (DE-588)123243327 |0 (DE-627)706224078 |0 (DE-576)293619174 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Supportive care in cancer |d Berlin : Springer, 1993 |g 27(2019), 7, Seite 2699-2705 |h Online-Ressource |w (DE-627)254909574 |w (DE-600)1463166-0 |w (DE-576)074754076 |x 1433-7339 |7 nnas |a Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy a randomised, double-blind, placebo-controlled, dose-ranging trial |
| 773 | 1 | 8 | |g volume:27 |g year:2019 |g number:7 |g pages:2699-2705 |g extent:7 |a Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy a randomised, double-blind, placebo-controlled, dose-ranging trial |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00520-018-4564-8 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00520-018-4564-8 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20190722 | ||
| 993 | |a Article | ||
| 994 | |a 2019 | ||
| 998 | |g 123243327 |a Jordan, Karin |m 123243327:Jordan, Karin |d 910000 |d 910100 |e 910000PJ123243327 |e 910100PJ123243327 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 999 | |a KXP-PPN1669583937 |e 3495613404 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["J. Herrstedt, Y. Summers, K. Jordan, J. von Pawel, A.H. Jakobsen, M. Ewertz, S. Chan, J.D. Naik, M. Karthaus, S. Dubey, R. Davis, G.M. Fox"]},"recId":"1669583937","note":["First online: 28 November 2018","Gesehen am 22.07.2019"],"title":[{"title_sort":"Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy","subtitle":"a randomised, double-blind, placebo-controlled, dose-ranging trial","title":"Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy"}],"person":[{"given":"Jørn","family":"Herrstedt","display":"Herrstedt, Jørn","role":"aut"},{"role":"aut","family":"Jordan","display":"Jordan, Karin","given":"Karin"}],"physDesc":[{"extent":"7 S."}],"relHost":[{"part":{"volume":"27","pages":"2699-2705","text":"27(2019), 7, Seite 2699-2705","year":"2019","extent":"7","issue":"7"},"title":[{"subtitle":"official journal of the Multinational Association of Supportive Care in Cancer","title":"Supportive care in cancer","title_sort":"Supportive care in cancer"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Berlin ; Heidelberg ; New York,NY","dateIssuedDisp":"1993-","dateIssuedKey":"1993","publisher":"Springer"}],"language":["eng"],"id":{"eki":["254909574"],"zdb":["1463166-0"],"issn":["1433-7339"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.1993 -"],"recId":"254909574","note":["Gesehen am 06.12.05"],"disp":"Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy a randomised, double-blind, placebo-controlled, dose-ranging trialSupportive care in cancer"}],"language":["eng"],"id":{"eki":["1669583937"],"doi":["10.1007/s00520-018-4564-8"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"2019"}]} | ||
| SRT | |a HERRSTEDTJAMISULPRID2019 | ||